AQR Capital Management - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 87 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2021$366,000
+577.8%
1,024,514
+1048.8%
0.00%
Q3 2021$54,000
-79.9%
89,183
-63.1%
0.00%
Q2 2021$268,000241,4690.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 432,503$554,0000.09%
MONECO Advisors, LLC 35,000$45,0000.02%
Purus Wealth Management, LLC 15,000$19,0000.02%
Renaissance Technologies 8,454,364$10,822,0000.01%
LMR Partners LLP 390,864$500,0000.01%
ExodusPoint Capital Management, LP 595,459$762,0000.01%
LINCOLN CAPITAL CORP 12,000$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 264,500$339,0000.01%
HRT FINANCIAL LP 347,816$445,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 25,000$32,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders